Skip to main content
icon for Flu Hospitalization Rate Week 23, 2026?

Flu Hospitalization Rate Week 23, 2026?

icon for Flu Hospitalization Rate Week 23, 2026?

Flu Hospitalization Rate Week 23, 2026?

jun 19

jun 19

85–90 94.2%

90–95 4.8%

95–100 <1%

<80 <1%

Polymarket
NOVO

85–90 94.2%

90–95 4.8%

95–100 <1%

<80 <1%

Polymarket
NOVO

<80

$397 Vol.

<1%

80–85

$397 Vol.

<1%

85–90

$3,036 Vol.

94%

90–95

$143 Vol.

5%

95–100

$245 Vol.

1%

100+

$455 Vol.

<1%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market-implied odds of 95.7% for an 85–90 cumulative flu hospitalization rate per 100,000 population through CDC Week 23 reflect the 2025–2026 season’s trajectory, with FluSurv-NET data showing 87.5 by Week 22 and only minimal weekly additions (0.1–0.3 per 100,000) in recent low-activity periods. Late-spring declines in laboratory-confirmed admissions, driven by waning influenza circulation after a moderately severe season peaking earlier, support little further accumulation before the June 22 data release. Historical patterns of negligible summer transmission reinforce trader consensus that the cumulative total will remain within this narrow band. An atypical off-season resurgence or delayed reporting adjustments could push the figure outside 85–90, though current surveillance trends indicate low probability.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$4,562
Data de Término
19 jun 2026
Mercado Aberto
Jun 12, 2026, 7:22 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market-implied odds of 95.7% for an 85–90 cumulative flu hospitalization rate per 100,000 population through CDC Week 23 reflect the 2025–2026 season’s trajectory, with FluSurv-NET data showing 87.5 by Week 22 and only minimal weekly additions (0.1–0.3 per 100,000) in recent low-activity periods. Late-spring declines in laboratory-confirmed admissions, driven by waning influenza circulation after a moderately severe season peaking earlier, support little further accumulation before the June 22 data release. Historical patterns of negligible summer transmission reinforce trader consensus that the cumulative total will remain within this narrow band. An atypical off-season resurgence or delayed reporting adjustments could push the figure outside 85–90, though current surveillance trends indicate low probability.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$4,562
Data de Término
19 jun 2026
Mercado Aberto
Jun 12, 2026, 7:22 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Cuidado com os links externos.

Frequently Asked Questions

"Flu Hospitalization Rate Week 23, 2026?" is a prediction market on Polymarket with 6 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "85–90" at 94%, followed by "90–95" at 5%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 94¢ implies that the market collectively assigns a 94% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"Flu Hospitalization Rate Week 23, 2026?" is a newly created market on Polymarket, launched on Jun 13, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "Flu Hospitalization Rate Week 23, 2026?," browse the 6 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Flu Hospitalization Rate Week 23, 2026?" is "85–90" at 94%, meaning the market assigns a 94% chance to that outcome. The next closest outcome is "90–95" at 5%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Flu Hospitalization Rate Week 23, 2026?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.